By the Top Tier Newswire AI Desk · August 26, 2026 at 12:21 AM ET · reviewed against 1 wire stories
MINIMED GROUP INC (MMED) is down -5.12% in the latest session. Our newswire has captured 1 story on MMED across 1 source in the last 36 hours, with AI sentiment reading mixed (avg 56/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Why MMED stock is down today
MiniMed Group Inc (MMED) fell 5.12% to $18.92 in intraday trading on August 26, 2026. The decline comes amid a broader market session that saw 29 stocks print fresh 52-week lows on the same day. The stock’s downward movement appears to reflect broader market weakness rather than a direct reaction to recent company-specific news.
What Happened
MiniMed announced that its management will participate in fireside chats at upcoming investor conferences, but the news has not yet translated into positive price action. The company remains unprofitable with a trailing twelve-month (TTM) net margin of -10.7% and an earnings per share (EPS) of -1.30. Despite a 14.3% year-over-year revenue increase, the stock has struggled to gain traction amid ongoing profitability challenges.
Wells Fargo recently lowered its price target for MMED to $22 while maintaining an Overweight rating. The stock is currently trading below this updated target. A full transcript of MiniMed’s Q4 2026 earnings call was published recently, and the company is scheduled to report earnings again on June 3, 2026. Investors may be anticipating further clarity on the company’s financial performance and strategic direction.
What The Data Shows
The stock has traded within a 52-week range of $10.65 to $20.88. On August 26, it printed a fresh 52-week low. The session’s volume and unusual options activity were not reported, but the broader market context suggests that retail and institutional investors may be taking a cautious stance. The stock’s current price of $18.92 reflects a market capitalization of $5.7 billion.
What To Watch
Investors should monitor MiniMed’s earnings report on June 3, 2026, for further insight into the company’s financial health and growth trajectory. Coverage breadth and analyst reactions to the report will be key to assessing the stock’s near-term direction.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
MMED · Aug 26 session (5-min) · +5.66% vs prior close · updated 8:51 PM ETAI sentiment, last 36h · averaged over 1 story · 56/100 bullish
The headlines behind the move
Story flow · 1 story on the wire, last 36h · hover or tap a dot for the headline
19d agoPR NewswireBULLISH 56General
MiniMed to Participate in Upcoming Investor Conferences
NORTHRIDGE, Calif., Aug. 25, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that management will participate in fireside chats at the following investor conferences: 21st Annual Wells Fargo Healthcare Conference Tuesday, September 8,...
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →